David Ren, PhD
Director of Analytical Science & Technology, Global QC in Novartis Gene Therapies
Peter Clarner
Scientist I, Gene Therapy Accelerator Unit (GTxAU) ‑ Biogen
Russell Goetze, PhD
Scientist II ‑ Bluebird Bio
David Dobnik, PhD
Scientific Associate ‑ National Institute of Biology
Track 1
Cell and Gene Therapy
Session 1: ddPCR Assay Development for AAV GMP Quality Control
Session 2: Applications of Droplet Digital PCR in Assessing AAV‑based Gene Therapy Performance
Session 3: Applying ddPCR to Characterize Starting Materials for Advanced CAR-T Cell Therapies
Session 4: The Role of Droplet Digital PCR in Characterization of Viral Vectors for Gene Therapy
Session 5: Panel discussion to follow afterwards
Watch on‑demand now